Common variants associated with plasma triglycerides and risk for coronary artery disease
about
Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 personsTM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet contentTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseTriglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?The impact of genome-wide association studies on the pathophysiology and therapy of cardiovascular diseaseHypertriglyceridemia and Cardiovascular Diseases: RevisitedNeuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeInsights into blood lipids from rare variant discoveryMendelian randomization: genetic anchors for causal inference in epidemiological studiesGenome-wide association studies of late-onset cardiovascular diseaseMendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the futureThe emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolismGenome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markersGene-Lifestyle Interactions in Complex Diseases: Design and Description of the GLACIER and VIKING StudiesLarge-scale metabolomic profiling identifies novel biomarkers for incident coronary heart diseaseModulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expressionGenetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentMendelian randomization in cardiometabolic disease: challenges in evaluating causality.The Role of Emerging Risk Factors in Cardiovascular OutcomesHypertriglyceridemia: the importance of identifying patients at risk.Leveraging human genetics to guide drug target discovery.Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosisLoss-of-function mutations in APOC3, triglycerides, and coronary diseaseAssociation of the ST3GAL4 rs11220462 polymorphism and serum lipid levels in the Mulao and Han populationsSULF2 strongly prediposes to fasting and postprandial triglycerides in patients with obesity and type 2 diabetes mellitus.Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure.Amerindian-specific regions under positive selection harbour new lipid variants in Latinos.Skin pigmentation, sun exposure and vitamin D levels in children of the Avon Longitudinal Study of Parents and ChildrenReading and language disorders: the importance of both quantity and quality.Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type 2 diabetes, cardiovascular diseases, and cancer: a systematic reviewA rare variant in APOC3 is associated with plasma triglyceride and VLDL levels in Europeans.Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucomaThe polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management.Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglyceridesAtherogenic dyslipidemia and cardiovascular risk factors in obese childrenPlasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk FactorsVery-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.Genetics of coronary artery disease: discovery, biology and clinical translation.
P2860
Q21562282-4D2392D4-BDFE-4474-8167-721B6BCEEC4FQ24299190-DDD48F2C-1F00-4172-83F9-A5028B41C1A9Q26745946-04B1D475-48BB-4D8A-8B42-57370CBD7EDAQ26746279-4FE26D87-D447-4803-A798-E19F1184CC73Q26748869-2492F51E-EFBF-42DE-9B1A-08404C99745FQ26750954-1D2BEE98-5744-45D0-9A00-1B53D6E61C8DQ26752744-5D5AFE96-C4BC-44A2-ADF6-BC9D126D3EE1Q26799138-573244D7-F55F-4FFC-AFBE-48597A001AB7Q27002487-92F0FFE7-157C-4F25-A406-9930F55CC71AQ27012711-A94D1216-86D8-4CB3-9548-D84D9967CC39Q28070061-7EC10DF1-4AB5-40F6-A258-BDF8D2EAF4E1Q28072835-3C9711AB-8994-4530-966B-01A81535D0FCQ28267312-2B90C7AC-F05E-4CF3-86C1-EA3692DFB85AQ28397345-6E333E98-C8CD-4046-9AD9-4E23A11526E3Q28542665-E456BE76-BD05-4EB3-9E80-494491F865D5Q28545029-EB6FB017-ABDD-499E-B722-F355532D04FDQ30000080-EDAAE01C-152F-47FD-9682-03BD9EDF4894Q30234302-8F7D7DF3-9CBD-440A-99B6-1872721AA8FBQ30234550-89560E99-4CAA-4E8F-B998-0F4CE4D6EF96Q30244825-F4BA4236-2A2B-4352-90EF-830F098A1EE5Q30245007-B34C2B4E-D23D-452A-AB76-3C329E55298FQ30301147-3DD5C174-35A8-4A3C-915B-A6E0E0E4D973Q30303053-962C67B0-E650-41D5-B12A-95C7978F2737Q30408720-3849E7B8-B066-4D84-B535-DDE9484E36F6Q30599909-C67B1B1F-16BF-4A9E-AC94-185CA382E90EQ33560966-C838ADE5-F3E6-4F45-9183-64861E0DB079Q33765836-8BC66246-7FF2-4159-B0C7-37D358A91314Q33772642-F56AB351-7511-41AD-9020-B0E0EC5698F4Q33792547-1BC0F4A0-D161-4F1F-A690-5A781DD74888Q33891684-3A090035-2446-4418-89DB-ED0E8D258699Q33893037-3C81C18C-AA97-4676-AA14-843D90153010Q34205523-66055C22-C70E-4541-9FD2-3B7D16DCDB6AQ34254081-DBAAC1A0-D1BC-49AB-A5A2-36CF6E038057Q34359967-60447E4F-472C-44C7-A456-66B499856887Q34406987-06058C99-6A41-4392-85CF-7EF5B8ECC663Q34461856-2250AD36-B8FE-4022-9359-D1F2F32D7212Q34480492-CFF68B5D-E8EA-4DF9-B630-7B01E2D7066DQ34498817-4D783BF8-F978-4632-9A16-E66371F0AAC6Q34551430-34113422-34AB-4B9C-9A44-E9A1EECBCC23Q34553141-FB3DD6D5-A8E4-4383-BB26-38D216C3B68B
P2860
Common variants associated with plasma triglycerides and risk for coronary artery disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Common variants associated with plasma triglycerides and risk for coronary artery disease
@ast
Common variants associated with plasma triglycerides and risk for coronary artery disease
@en
Common variants associated with plasma triglycerides and risk for coronary artery disease
@nl
type
label
Common variants associated with plasma triglycerides and risk for coronary artery disease
@ast
Common variants associated with plasma triglycerides and risk for coronary artery disease
@en
Common variants associated with plasma triglycerides and risk for coronary artery disease
@nl
prefLabel
Common variants associated with plasma triglycerides and risk for coronary artery disease
@ast
Common variants associated with plasma triglycerides and risk for coronary artery disease
@en
Common variants associated with plasma triglycerides and risk for coronary artery disease
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
Common variants associated with plasma triglycerides and risk for coronary artery disease
@en
P2093
Alan B Feranil
Amy J Swift
Andrew D Morris
Antero Kesäniemi
Aravinda Chakravarti
Bamidele O Tayo
Bernhard O Boehm
Cameron D Palmer
Carlos Iribarren
Chao Agnes Hsiung
P2860
P2888
P304
P3181
P356
10.1038/NG.2795
P407
P50
P577
2013-10-06T00:00:00Z